Base editing utilizes enzymes to modify single amino acids at the most foundational unit of DNA, called a base.

This study details the design and optimization of synXVI, a synthetic yeast chromosome, overcoming growth challenges through ...

CRISPR is a technology that can be used to edit genes and, as such, will likely change the world. The essence of CRISPR is simple: it’s a way of finding a specific bit of DNA inside a cell.

By exploring single cell RNA-sequencing data from clinical trials using CRISPR-Cas9 engineered T cells, the researchers found that a clinical trial using a different protocol, where scientists edited ...

Macquarie University researchers have worked with an international team of scientists to achieve a major milestone in ...

The completion of chromosome synXVI allows scientists to explore new possibilities in metabolic engineering and strain ...

Scientists have completed construction of the final chromosome in the worlds' first synthetic yeast genome following more than a decade of work, opening new possibilities for creating resilient, ...

Then Crispr came along—the elegant enzymatic apparatus that allows delivery of DNA scissors to a specific target in the genome. In December 2023, the FDA approved the first Crispr-based therapy ...

“The important part is that [Tsuchida’s team] demonstrated a way to mitigate unintended chromosome loss by changing the protocol,” said Ayal Hendel, a CRISPR editing researcher from Bar-Ilan ...

CRISPR Therapeutics' stock decline is likely influenced by Editas Medicine's struggles, but CRISPR remains a distinct and stronger company with a promising long-term outlook. CRISPR's strategic ...

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.